Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 47 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 9458141

    Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  2. US 9457132

    Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  3. US 9458215

    Compositions and methods for osteogenic gene therapy

    The United States of America as represented by the Department of Veteran Affairs · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  4. US 9458086

    Compositions and methods for adipocyte modulation

    The United States of America as Represented by the Department of Veterans Affairs Office of General Counsel—PSG IV (024) · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted

  5. US 9453019

    Linked purine pterin HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  6. US 9452973

    Modulators of the relaxin receptor 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  7. US 9453239

    Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes

    The Government of the United States of America, as represented by the Secretary Department of Health and Human Services, National Institutes of Health · Granted Sep 27, 2016 · Expires Sep 22, 2036

    granted

  8. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  9. US 9446048

    Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted

  10. US 9441019

    Influenza hemagglutinin protein-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  11. US 9439935

    Recombinant rift valley fever (RVF) viruses and methods

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  12. US 9441048

    Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  13. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  14. US 9439875

    Anxiolytic effect of pterostilbene

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  15. US 9439978

    Multilayered magnetic micelle compositions and methods for their use

    The United States of America as represented by National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), U.S. Government · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  16. US 9441050

    High-affinity monoclonal anti-prion antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  17. US 9441022

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  18. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted

  19. US 9435000

    Primate T-lymphotropic viruses

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 6, 2016 · Expires Sep 1, 2036

    granted

  20. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  21. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  22. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  23. US 9421250

    Pathogenic phlebovirus isolates and compositions and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  24. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.